Related Experiment Videos

Creutzfeldt-Jakob disease with long duration and panencephalopathic lesions: molecular analysis of one case

I Ghorayeb1, C Series, P Parchi

  • 1Department of Internal Medicine, Victor Segalen University, Bordeaux, France.

Neurology
|July 23, 1998
PubMed

Insights

This study details a rare panencephalopathic variant of Creutzfeldt-Jakob disease (CJD). Findings suggest this severe brain degeneration represents an end-stage condition across various CJD types, especially in prolonged cases.

Area of Science:

  • Neuroscience
  • Neuropathology
  • Prion Diseases

Background:

  • Creutzfeldt-Jakob disease (CJD) is a rare, fatal neurodegenerative disorder.
  • CJD is characterized by rapidly progressive dementia and neurological decline.
  • Understanding CJD variants is crucial for diagnosis and management.

Observation:

  • A 49-year-old woman presented with a 4-year history of aphasia, dementia, and ataxia.
  • Histopathology revealed panencephalic involvement, status spongiosus, and kuru-type plaques.
  • Molecular analysis identified heterozygosity at codon 129 of the prion protein (PrP) gene and type 2 protease-resistant PrP.

Findings:

  • The observed panencephalopathic changes suggest an end-stage condition.
  • This presentation aligns with a prolonged course of Creutzfeldt-Jakob disease.
  • The findings indicate panencephalopathy may be an aspecific feature of CJD variants.

Implications:

  • The panencephalopathic variant of CJD may not be a distinct subtype but an end-stage manifestation.
  • This broadens the understanding of CJD pathology and its diverse presentations.
  • Further research into prolonged CJD courses and their pathological correlates is warranted.

Related Concept Videos